4//SEC Filing
Bracken Racquel 4
Accession 0000899243-22-007646
CIK 0001662244other
Filed
Feb 23, 7:00 PM ET
Accepted
Feb 24, 4:59 PM ET
Size
6.2 KB
Accession
0000899243-22-007646
Insider Transaction Report
Form 4
Bracken Racquel
Director
Transactions
- Award
Stock Option (Right to Buy)
2022-02-22+14,150→ 14,150 totalExercise: $5.96Exp: 2032-02-22→ Common Stock (14,150 underlying)
Footnotes (2)
- [F1]The shares of common stock underlying this stock option award vest in full on February 22, 2023, subject to the Reporting Person's continued service to the board of directors of the Company through the applicable vesting date.
- [F2]Under an agreement between the Reporting Person and VR Management, LLC (the "Management Company"), the Reporting Person is deemed to hold the reported shares for the sole benefit of the Management Company and must exercise the reported shares solely upon the direction of the Management Company, which is entitled to the shares. The Management Company may be deemed the indirect beneficial owner of the reported shares, and the Reporting Person may be deemed the indirect beneficial owner of the reported shares through her interest in the Management Company. The Reporting Person disclaims beneficial ownership of the reported shares except to the extent of her pecuniary interest therein.
Documents
Issuer
Cyteir Therapeutics, Inc.
CIK 0001662244
Entity typeother
Related Parties
1- filerCIK 0001864337
Filing Metadata
- Form type
- 4
- Filed
- Feb 23, 7:00 PM ET
- Accepted
- Feb 24, 4:59 PM ET
- Size
- 6.2 KB